Intravenous thrombolysis and mechanical thrombectomy in acute stroke patients on direct oral anticoagulants
Journal of Neurology · 2025-01 · 272 (1)
DOI: 10.1007/s00415-024-12832-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neurology, online erschienen am 21.12.2024. Verfasst von Espen Saxhaug Kristoffersen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Akershus University Hospital, PO Box 1000, 1478, Lørenskog, Norway. e.s.kristoffersen@medisin.uio.no. Hauptthemen laut MEDLINE: Anticoagulants, Thrombolytic Therapy, Ischemic Stroke. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Oslo.
Themen: Schlaganfall
Abstract (Originalsprache)
Intravenous thrombolysis and mechanical thrombectomy reduce morbidity and improve functional outcome in ischemic stroke. However, acute recanalization therapies may increase the risk of symptomatic intracranial hemorrhage due to its effects on the brain tissue. An increasing proportion of patients with ischemic stroke are using direct oral anticoagulants (DOACs). While current international guidelines recommend against intravenous thrombolysis in patients with intake of DOACs within the last 48 h, they also highlight lack of evidence in the area. Based on these guidelines, a significant proportion of patients are consequently disqualified from intravenous thrombolysis. Measuring anticoagulant activity before intravenous thrombolysis has been suggested as a way to select patients with low risk of symptomatic intracranial hemorrhage, but uncertainty exists about feasibility, validity, availability and costs. Reversal agents have demonstrated potential in facilitating safer intravenous thrombolysis administration, though their efficacy is not established in randomized controlled trials, and logistical and cost-related barriers limit their widespread use. During the last couple of years several large cohort studies reported no significant increase in symptomatic intracranial hemorrhage among selected patients on DOACs receiving intravenous thrombolysis compared to those not on anticoagulants, even without the use of DOAC plasma levels or reversal agents. Mechanical thrombectomy appears to be generally safe in patients with recent DOAC intake. The aim of this review is to discuss the uncertainty around the safety and efficacy of intravenous thrombolysis and thrombectomy in patients with a recent intake of DOAC, summarize existing knowledge, and outline potential approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Akershus University Hospital, PO Box 1000, 1478, Lørenskog, Norway. e.s.kristoffersen@medisin.uio.no.
- Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway. e.s.kristoffersen@medisin.uio.no.
- Department of Neurology, Inselspital Bern University Hospital and University of Bern, Bern, Switzerland.
Förderung
- University of Oslo
Zitieren
APA
Kristoffersen, E. S., Seiffge, D. J., & Meinel, T. R. (2025). Intravenous thrombolysis and mechanical thrombectomy in acute stroke patients on direct oral anticoagulants. Journal of Neurology, 272(1). https://doi.org/10.1007/s00415-024-12832-0
Vancouver
Kristoffersen ES, Seiffge DJ, Meinel TR. Intravenous thrombolysis and mechanical thrombectomy in acute stroke patients on direct oral anticoagulants. Journal of Neurology. 2025;272(1). doi:10.1007/s00415-024-12832-0
BibTeX
@article{Kristoffersen2025,
author = {Kristoffersen, Espen Saxhaug and Seiffge, David Julian and Meinel, Thomas Raphael},
title = {Intravenous thrombolysis and mechanical thrombectomy in acute stroke patients on direct oral anticoagulants},
journal = {Journal of Neurology},
year = {2025},
volume = {272},
number = {1},
doi = {10.1007/s00415-024-12832-0}
}
EUVIMED